Related Experiment Video

Updated: Jul 16, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

Key signaling pathways and targets in lung cancer therapy

Nicholas W Choong1, Ravi Salgia, Everett E Vokes

  • 1Section of Hematology/Oncology, University of Chicago Medical Center, IL 60615, USA.

Clinical Lung Cancer
|March 27, 2007
PubMed

Insights

Lung cancer treatment remains challenging. This review explores complex molecular targets and signaling pathways, aiming to improve lung cancer therapies through targeted inhibitors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Lung cancer treatment outcomes remain poor despite established therapies like chemotherapy, radiation, and surgery.
  • The complex molecular mechanisms of lung cancer involve oncogenes, tumor suppressor genes, and various cellular signaling pathways.
  • There is a critical need for novel therapeutics to improve patient outcomes.

Purpose of the Study:

  • To review key signaling pathways implicated in lung cancer.
  • To identify and discuss crucial molecular targets for lung cancer therapy.
  • To highlight the potential of targeted inhibitors in revolutionizing lung cancer treatment.

Main Methods:

  • Literature review of current research on lung cancer molecular mechanisms.
  • Analysis of signaling pathways and molecular targets in lung carcinogenesis.
  • Discussion of existing and emerging targeted therapeutic strategies.

Main Results:

  • Identification of multiple critical signaling pathways driving lung cancer development.
  • Characterization of key molecular targets, including receptor tyrosine kinases and oncogenes.
  • Emphasis on the complexity of lung cancer biology requiring multifaceted therapeutic approaches.

Conclusions:

  • Understanding molecular targets is essential for developing effective lung cancer treatments.
  • Targeted inhibitors show promise for significantly impacting lung cancer biology and therapy.
  • Further research into molecular mechanisms can lead to improved therapeutic strategies and patient outcomes.

More Related Videos

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...